Assyro AI

Orange Book product · Brand (NDA)

SUCCINYLCHOLINE CHLORIDE

SUCCINYLCHOLINE CHLORIDE

Brand (NDA)NDA 215143DISCN HIKMA

At a glance

Aug 20, 2021

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 20, 2021

    4 yr 11 mo ago

  2. Today

  3. Patent 12295932 expires

    Listed drug product patent expiration.

    Nov 02, 2041

    in 15 yr 7 mo

Pharmaceutical detail

Active ingredient

SUCCINYLCHOLINE CHLORIDE

Strength

100MG/5ML (20MG/ML)

Dosage form

SOLUTION

Route

INTRAMUSCULAR, INTRAVENOUS

TE code

Not listed

Application

NDA 215143

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
12295932Nov 02, 2041in 15 yr 7 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.